Exelixis Inc Fair Value Adjustment of Warrants
Exelixis Inc (EXEL) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2017-12-29, per its 10-K filed 2018-02-26.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2018-02-26
- Exelixis Inc fair value adjustment of warrants for the quarter ending 2016-12-31 was $0.00.
- Exelixis Inc fair value adjustment of warrants for the quarter ending 2016-09-30 was $0.00.
- Exelixis Inc fair value adjustment of warrants for the quarter ending 2016-06-30 was $0.00.
- Exelixis Inc fair value adjustment of warrants for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- Exelixis Inc fair value adjustment of warrants for fiscal 2017 was $0.00.
- Exelixis Inc fair value adjustment of warrants for fiscal 2016 was $0.00.
- Exelixis Inc fair value adjustment of warrants for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2016.
- Exelixis Inc fair value adjustment of warrants for fiscal 2016 was $548.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2017-12-29 | $0.00 10-K · filed 2018-02-26 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $0.00 derived: sum of 2 quarters · filed 2017-02-27 | $0.00 derived: sum of 3 quarters · filed 2017-02-27 | $0.00 10-K · filed 2017-02-27 |
| 2016-12-30 | $0.00 10-K · filed 2018-02-26 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $0.00 10-Q · filed 2016-11-03 | -$1.00K derived: sum of 4 quarters · filed 2017-02-27 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $0.00 10-Q · filed 2016-08-03 | -$1.00K derived: sum of 3 quarters · filed 2017-02-27 | -$1.00K derived: sum of 4 quarters · filed 2017-02-27 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-04 | -$1.00K derived: sum of 2 quarters · filed 2017-02-27 | -$1.00K derived: sum of 3 quarters · filed 2017-02-27 | -$1.00K derived: sum of 4 quarters · filed 2017-02-27 |
| 2016-01-01 | $548.00K 10-K · filed 2018-02-26 | |||
| 2015-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$1.00K derived: sum of 2 quarters · filed 2017-02-27 | -$1.00K derived: sum of 3 quarters · filed 2017-02-27 | $548.00K 10-K · filed 2017-02-27 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $549.00K 10-Q · filed 2016-11-03 | $625.00K derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $549.00K 10-Q · filed 2016-08-03 | $625.00K derived: sum of 3 quarters · filed 2017-02-27 | $563.00K derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | $549.00K 10-Q · filed 2016-05-04 | $625.00K derived: sum of 2 quarters · filed 2017-02-27 | $563.00K derived: sum of 3 quarters · filed 2017-02-27 | $448.00K derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $14.00K derived: sum of 2 quarters · filed 2017-02-27 | -$101.00K derived: sum of 3 quarters · filed 2017-02-27 | -$1.84M 10-K · filed 2017-02-27 |
| 2014-09-30 | -$62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | -$177.00K derived: sum of 2 quarters · filed 2015-11-10 | -$1.92M 10-Q · filed 2015-11-10 | -$1.92M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$115.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | -$1.85M 10-Q · filed 2015-08-11 | -$1.85M derived: sum of 3 quarters · filed 2016-02-29 | -$1.85M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | -$1.74M 10-Q · filed 2015-04-30 | -$1.74M derived: sum of 2 quarters · filed 2016-02-29 | -$1.74M derived: sum of 3 quarters · filed 2016-02-29 | -$1.74M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $0.00 derived: sum of 3 quarters · filed 2016-02-29 | $0.00 10-K · filed 2016-02-29 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $0.00 derived: sum of 2 quarters · filed 2014-11-04 | $0.00 10-Q · filed 2014-11-04 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $0.00 10-Q · filed 2014-07-31 | ||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-01 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |